title: Tissue engineering and regenerative medicine: semantic considerations for an evolving paradigm.
abstract: Tissue engineering (TE) and regenerative medicine (RM) are rapidly evolving fields that are often obscured by a dense cloud of hype and commercialization potential. We find, in the literature and general commentary, that several of the associated terms are casually referenced in varying contexts that ultimately result in the blurring of the distinguishing boundaries which define them. "TE" and "RM" are often used interchangeably, though some experts vehemently argue that they, in fact, represent different conceptual entities. Nevertheless, contemporary scientists have a general idea of the experiments and milestones that can be classified within either or both categories. Given the groundbreaking achievements reported within the past decade and consequent watershed potential of this field, we feel that it would be useful to properly contextualize these terms semantically and historically. In this concept paper, we explore the various definitions proposed in the literature and emphasize that ambiguous terminology can lead to misplaced apprehension. We assert that the central motifs of both concepts have existed within the surgical sciences long before their appearance as terms in the scientific literature.
authors: Wake Forest School of Medicine , Winston-Salem, NC , USA.
authors: Ravi
authors: R
authors: Katari
authors: Wake Forest School of Medicine , Winston-Salem, NC , USA ; General Surgery, Fondazione IRCCS Policlinico San Matteo Pavia, University of Pavia , Pavia , Italy.
authors: Andrea
authors: A
authors: Peloso
authors: Wake Forest School of Medicine , Winston-Salem, NC , USA.
authors: Giuseppe
authors: G
authors: Orlando
keywords: commercialization; device regulation; organ bioengineering; regenerative medicine; stem cells; tissue engineering
references: Proc Natl Acad Sci U S A. 2003 Sep 30;100 Suppl 1:11830-5
references: 12913119
references: J Tissue Eng Regen Med. 2007 May-Jun;1(3):179-84
references: 18038409
references: J Clin Invest. 2004 Sep;114(6):795-804
references: 15372103
references: Front Immunol. 2012 Aug 14;3:253
references: 22912639
references: Biologicals. 2012 May;40(3):222-4
references: 22374355
references: Lancet. 2014 Jan 18;383(9913):238-44
references: 24161821
references: Biomaterials. 2013 Aug;34(24):5915-25
references: 23680364
references: Int Rev Neurobiol. 2013;108:1-33
references: 24083429
references: Bioessays. 2013 Mar;35(3):163-72
references: 22996568
references: Nature. 2007 Feb 22;445(7130):834-42
references: 17314969
references: Regen Med. 2009 Mar;4(2):147-8
references: 19317632
references: Nat Biotechnol. 2014 Aug;32(8):721-3
references: 25093890
references: Tissue Eng Part A. 2008 Feb;14(2):305-15
references: 18333783
references: Am J Pathol. 2005 Feb;166(2):545-55
references: 15681837
references: Tissue Eng Part B Rev. 2013 Feb;19(1):1-13
references: 23253031
references: Tissue Eng Part B Rev. 2010 Feb;16(1):41-54
references: 19728784
references: Trans Am Ophthalmol Soc. 1984;82:187-202
references: 6398933
references: Cold Spring Harb Perspect Med. 2013 Aug 01;3(8):null
references: 23906883
references: Regen Med. 2012 Nov;7(6 Suppl):94-7
references: 23210819
references: Urology. 1999 Sep;54(3):407-10
references: 10475343
references: Ann Surg. 2013 Aug;258(2):221-32
references: 23782908
references: Cytotherapy. 2014 Mar;16(3):289-97
references: 24113428
references: Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3285-6
references: 20181571
references: J Pediatr Surg. 1988 Jan;23(1 Pt 2):3-9
references: 2895175
references: Adv Surg. 2014;48:137-54
references: 25293612
references: Transplantation. 2011 Jun 27;91(12):1310-7
references: 21505379
references: Tissue Eng. 2004 Jan-Feb;10(1-2):309-20
references: 15009955
references: Laryngoscope. 1987 Feb;97(2):239-40
references: 3543582
references: Circulation. 2003 Oct 7;108(14):1729-34
references: 12963635